Objectives: Our objective was to evaluate whether vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) prevents the incidence of community-acquired pneumonia (CAP) caused by influenza (influenza-associated CAP, IA-CAP) or other respiratory viruses in the elderly. Methods: This analysis was part of the Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA); a double blind, randomized, placebo-controlled trial in 84 496 immunocompetent individuals aged ≥65 years. CAP was defined by clinical and radiological criteria, and oropharyngeal swabs were collected from all individuals referred to a sentinel centre with a clinical suspicion of pneumonia. Presence of influenza A and B, parainfluenza 1, 2, 3 and 4, human aden...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
BACKGROUND: The incidence of community-acquired pneumonia (CAP) almost triples for older adults aged...
Background: The impact of pneumococcal conjugate vaccination on the prevalence of nasopharyngeal car...
The burden of community-acquired pneumonia (CAP) among the elderly is high and has increased over th...
The burden of community-acquired pneumonia (CAP) among the elderly is high and has increased over th...
Objectives: The efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in adults to prevent co...
Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularl...
Globally, lower respiratory tract infections (LRTIs), including community-acquired pneumonia (CAP), ...
Pneumococcal community-acquired pneumonia (PCAP) and invasive pneumococcal disease (IPD) are importa...
Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularl...
Community-acquired pneumonia (CAP) is an important cause of morbidity and mortality worldwide. CAP i...
Introduction Hospitalisations and prolonged hospital stays impose great economic burden especially a...
Background. In the randomized controlled Community-Acquired Pneumonia Immunization Trial in Adults (...
Background: Pneumonia is one of the leading causes of mortality and has a high burden in morbidity. ...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
BACKGROUND: The incidence of community-acquired pneumonia (CAP) almost triples for older adults aged...
Background: The impact of pneumococcal conjugate vaccination on the prevalence of nasopharyngeal car...
The burden of community-acquired pneumonia (CAP) among the elderly is high and has increased over th...
The burden of community-acquired pneumonia (CAP) among the elderly is high and has increased over th...
Objectives: The efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in adults to prevent co...
Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularl...
Globally, lower respiratory tract infections (LRTIs), including community-acquired pneumonia (CAP), ...
Pneumococcal community-acquired pneumonia (PCAP) and invasive pneumococcal disease (IPD) are importa...
Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularl...
Community-acquired pneumonia (CAP) is an important cause of morbidity and mortality worldwide. CAP i...
Introduction Hospitalisations and prolonged hospital stays impose great economic burden especially a...
Background. In the randomized controlled Community-Acquired Pneumonia Immunization Trial in Adults (...
Background: Pneumonia is one of the leading causes of mortality and has a high burden in morbidity. ...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
Streptococcus pneumoniae is currently the leading cause of community-acquired pneumonia (CAP) and lo...
BACKGROUND: The incidence of community-acquired pneumonia (CAP) almost triples for older adults aged...